Dihydroartemisinin–piperaquine for the prevention of malaria in pregnancy
A Kakuru, P Jagannathan, MK Muhindo… - … England Journal of …, 2016 - Mass Medical Soc
Background Intermittent treatment with sulfadoxine–pyrimethamine is widely recommended
for the prevention of malaria in pregnant women in Africa. However, with the spread of …
for the prevention of malaria in pregnant women in Africa. However, with the spread of …
Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an …
EN Muthoka, K Usmael, SM Embaye, A Abebe… - Malaria Journal, 2023 - Springer
Background Malaria infection during pregnancy is an important cause of maternal and infant
mortality and morbidity with the greatest effect being concentrated in sub-Saharan Africa. In …
mortality and morbidity with the greatest effect being concentrated in sub-Saharan Africa. In …
Submicroscopic Plasmodium falciparum Infections Are Associated With Maternal Anemia, Premature Births, and Low Birth Weight
G Cottrell, A Moussiliou, AJF Luty, M Cot… - Clinical Infectious …, 2015 - academic.oup.com
Background. Molecular, as opposed to microscopic, detection measures the real prevalence
of Plasmodium falciparum infections. Such occult infections are common during pregnancy …
of Plasmodium falciparum infections. Such occult infections are common during pregnancy …
Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the …
JK Anchang-Kimbi, LN Kalaji, HF Mbacham… - Malaria journal, 2020 - Springer
Background Growing concerns about the waning efficacy of IPTp-SP warrants continuous
monitoring and evaluation. This study determined coverage of IPTp-SP and compared the …
monitoring and evaluation. This study determined coverage of IPTp-SP and compared the …
Fetal growth restriction is associated with malaria in pregnancy: a prospective longitudinal study in Benin
V Briand, J Saal, C Ghafari, BT Huynh… - The Journal of …, 2016 - academic.oup.com
Background. Few studies have evaluated the effect of malaria on intrauterine growth
restriction on the basis of the fetal growth rate, rather than just the small-for-gestational age z …
restriction on the basis of the fetal growth rate, rather than just the small-for-gestational age z …
[HTML][HTML] Resistance of plasmodium falciparum to sulfadoxine-pyrimethamine (dhfr and dhps) and artemisinin and its derivatives (K13): a major challenge for malaria …
The spread of resistance to antimalarials is a major public health problem worldwide and
especially in sub-Saharan Africa where the highest morbidity and mortality rates are found …
especially in sub-Saharan Africa where the highest morbidity and mortality rates are found …
Persistent Plasmodium falciparum Infection in Women With an Intent to Become Pregnant as a Risk Factor for Pregnancy-associated Malaria
N Tuikue Ndam, B Tornyigah, AY Dossou… - Clinical Infectious …, 2018 - academic.oup.com
Background Pregnant women are more susceptible to Plasmodium falciparum than before
pregnancy, and infection has consequences for both mother and offspring. The World Health …
pregnancy, and infection has consequences for both mother and offspring. The World Health …
A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates …
Background Malaria is a major public health issue with substantial risks among vulnerable
populations. Currently, the World Health Organization (WHO) recommends SP-IPTp in the …
populations. Currently, the World Health Organization (WHO) recommends SP-IPTp in the …
The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest …
Intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine (IPTp-
SP) is used to prevent malaria and associated unfavorable maternal and foetal outcomes in …
SP) is used to prevent malaria and associated unfavorable maternal and foetal outcomes in …
Intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery …
A Mama, C Ahiabor, B Tornyigah, NA Frempong… - Malaria Journal, 2022 - Springer
Background Despite decades of prevention efforts, the burden of malaria in pregnancy (MiP)
remains a great public health concern. Sulfadoxine-pyrimethamine (SP), used as intermittent …
remains a great public health concern. Sulfadoxine-pyrimethamine (SP), used as intermittent …